ISO 27001 certified and designed for flexible, efficient, secure, scalable and high-throughput, high-quality analyses, our state-of-the-art sequencing, bioinformatics and proteomics platforms are ready to be put to use for your research and clinical projects. Our mandate is to advance knowledge about cancer and other diseases, to improve human health through disease prevention, diagnosis and therapeutic approaches, and to realize the social and economic benefits of genomics research.
Our sequencing validation team offers several high quality, high throughput targeted sequencing services. Our clinical pipelines are College of American Pathologist (CAP) certified, including for panel testing and whole genome sequencing.
We produce quality data with high sensitivity and specificity and low false positives to discover novel variants, provide reliable database construction, data deposition and customized informatic services.
We perform collaborative proteomic research to characterize and quantify the changes to proteins and the proteome that drive tumourigenesis.
We provide access to diversity of cutting-edge sequencing and bioinformatics tools and techniques and can customize our services for your specific research or clinical project. Let us help you discover new possibilities by leveraging our expertise in scientific collaboration to design new approaches and technologies specific to your research questions. We look forward to hearing about how we can put our experience, skills and platforms to work for your projects. How can we help?
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.